Adrenergic signaling in heart failure and cardiovascular aging

Maturitas

Volumn 93, Issue , 2016, Pages 65-72

  Santulli, Gaetano ^a   Iaccarino, Guido ^b  

^a Columbia University Medical Center ^*  (United States)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Aging; Beta adrenergic receptors; Cardiovascular system; G protein coupled receptor kinases; Heart failure; Multimorbidity; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; NORADRENALIN;

ADRENERGIC SYSTEM; AGING; CARDIOVASCULAR SYSTEM; HEART FAILURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; REVIEW; SIGNAL TRANSDUCTION; PHYSIOLOGY;

AGING; CARDIOVASCULAR SYSTEM; HEART FAILURE; HUMANS; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 84962555413     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2016.03.022     Document Type: Review

References (134)

1. [1] Santulli, G., Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. J. Cardiovasc. Dis. 1:1 (2013), 1–2.
2. [2] Esler, M., Lambert, G., Kaye, D., Rumantir, M., Hastings, J., Seals, D.R., Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology 3:1–2 (2002), 45–49.
3. [3] Kaye, D., Esler, M., Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc. Res. 66:2 (2005), 256–264.
4. [4] Hatton, R., Cvjeticanin, A., Lymperopoulos, A., The adrenergic system of the adrenal glands as a remote control of cardiac function. J. Cardiovasc. Dis. 5:3 (2015), 394–397.
5. [5] Mei, Y., Yin, N., Jin, X., He, J., Yin, Z., The regulatory role of the adrenergic agonists phenylephrine and isoproterenol on fetal hemoglobin expression and erythroid differentiation. Endocrinology 154:12 (2013), 4640–4649.
6. [6] Lampri, E., Ioachim, E., Angiogenesis: something old, something new. Santulli, Gaetano, (eds.) Angiogenesis: Insight from a Systematic Overview, 2013, Nova Science Publishers, 1––30.
7. [7] O'Connell, T.D., Jensen, B.C., Baker, A.J., Simpson, P.C., Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol. Rev. 66:1 (2014), 308–333.
8. [8] Ruuskanen, J.O., Laurila, J., Xhaard, H., Rantanen, V.V., Vuoriluoto, K., Wurster, S., Marjamaki, A., Vainio, M., Johnson, M.S., Scheinin, M., Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors. Br. J. Pharmacol. 144:2 (2005), 165–177.
9. [9] Vicco, M.H., Pujato, N., Bontempi, I., Rodeles, L., Marcipar, I., Bottasso, O.A., Beta1-selective adrenoceptor antagonists increase plasma levels of anti-p2beta antibodies and decrease cardiac involvement in chronic progressive chagas heart disease. Can. J. Cardiol. 30:3 (2014), 332–337.
10. [10] Santulli, G., Iaccarino, G., Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun. Ageing, 10(1), 2013, 10.
11. [11] Belge, C., Hammond, J., Dubois-Deruy, E., Manoury, B., Hamelet, J., Beauloye, C., Markl, A., Pouleur, A.C., Bertrand, L., Esfahani, H., Jnaoui, K., Gotz, K.R., Nikolaev, V.O., Vanderper, A., Herijgers, P., Lobysheva, I., Iaccarino, G., Hilfiker-Kleiner, D., Tavernier, G., Langin, D., Dessy, C., Balligand, J.L., Enhanced expression of beta3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation 129:4 (2014), 451–462.
12. [12] Xiao, R.P., Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci. STKE, 2001(104), 2001, re15.
13. [13] Santulli, G., Lombardi, A., Sorriento, D., Anastasio, A., Del Giudice, C., Formisano, P., Beguinot, F., Trimarco, B., Miele, C., Iaccarino, G., Age-related impairment in insulin release: the essential role of beta(2)-adrenergic receptor. Diabetes 61:3 (2012), 692–701.
14. [14] Kaya, A.I., Onaran, H.O., Ozcan, G., Ambrosio, C., Costa, T., Balli, S., Ugur, O., Cell contact-dependent functional selectivity of beta2-adrenergic receptor ligands in stimulating cAMP accumulation and extracellular signal-regulated kinase phosphorylation. J. Biol. Chem. 287:9 (2012), 6362–6374.
15. [15] Santulli, G., Marks, A.R., Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging. Curr. Mol. Pharmacol. 8:2 (2015), 206–222.
16. [16] Yuan, Q., Chen, Z., Santulli, G., Gu, L., Yang, Z.G., Yuan, Z.Q., Zhao, Y.T., Xin, H.B., Deng, K.Y., Wang, S.Q., Ji, G., Functional role of calstabin2 in age-related cardiac alterations. Sci. Rep., 4, 2014, 7425.
17. [17] Gainetdinov, R.R., Bohn, L.M., Sotnikova, T.D., Cyr, M., Laakso, A., Macrae, A.D., Torres, G.E., Kim, K.M., Lefkowitz, R.J., Caron, M.G., Premont, R.T., Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38:2 (2003), 291–303.
18. [18] Lyubarsky, A.L., Chen, C., Simon, M.I., Pugh, E.N. Jr., Mice lacking G-protein receptor kinase 1 have profoundly slowed recovery of cone-driven retinal responses. J. Neurosci. 0:6 (2000), 2209–2217.
19. [19] Walker, J.K., Gainetdinov, R.R., Feldman, D.S., McFawn, P.K., Caron, M.G., Lefkowitz, R.J., Premont, R.T., Fisher, J.T., G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:2 (2004), L312–L319.
20. [20] Fusco, A., Santulli, G., Sorriento, D., Cipolletta, E., Garbi, C., Dorn 2nd, G.W., Trimarco, B., Feliciello, A., Iaccarino, G., Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell. Signal. 24:2 (2011), 468–475.
21. [21] Santulli, G., Campanile, A., Spinelli, L., Assante di Panzillo, E., Ciccarelli, M., Trimarco, B., Iaccarino, G., G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am. J. Cardiol. 107:8 (2011), 1125–1130.
22. [22] Suo, Z., Wu, M., Citron, B.A., Wong, G.T., Festoff, B.W., Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation. J. Neurosci. 24:13 (2004), 3444–3452.
23. [23] Lombardi, M.S., Kavelaars, A., Schedlowski, M., Bijlsma, J.W., Okihara, K.L., Van de Pol, M., Ochsmann, S., Pawlak, C., Schmidt, R.E., Heijnen, C.J., Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13:6 (1999), 715–725.
24. [24] Vroon, A., Kavelaars, A., Limmroth, V., Lombardi, M.S., Goebel, M.U., Van Dam, A.M., Caron, M.G., Schedlowski, M., Heijnen, C.J., G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Immunol. 174:7 (2005), 4400–4406.
25. [25] Singhmar, P., Huo, X., Eijkelkamp, N., Berciano, S.R., Baameur, F., Mei, F.C., Zhu, Y., Cheng, X., Hawke, D., Mayor, F. Jr., Murga, C., Heijnen, C.J., Kavelaars, A., Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1. Proc. Natl. Acad. Sci. U.S.A., 2016 in press.
26. [26] Zhang, J., Ferguson, S.S., Law, P.Y., Barak, L.S., Caron, M.G., Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin. J. Recept. Signal Transduct. Res. 19:1–4 (1999), 301–313.
27. [27] Metaye, T., Menet, E., Guilhot, J., Kraimps, J.L., Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 87:7 (2002), 3279–3286.
28. [28] Gatto, F., Feelders, R., van der Pas, R., Kros, J.M., Dogan, F., van Koetsveld, P.M., van der Lelij, A.J., Neggers, S.J., Minuto, F., de Herder, W., Lamberts, S.W., Ferone, D., Hofland, L.J., beta-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly. Endocrinology 154:12 (2013), 4715–4725.
29. [29] King, D.W., Steinmetz, R., Wagoner, H.A., Hannon, T.S., Chen, L.Y., Eugster, E.A., Pescovitz, O.H., Differential expression of GRK isoforms in nonmalignant and malignant human granulosa cells. Endocrine 22:2 (2003), 135–142.
30. [30] Roux, J., McNicholas, C.M., Carles, M., Goolaerts, A., Houseman, B.T., Dickinson, D.A., Iles, K.E., Ware, L.B., Matthay, M.A., Pittet, J.F., IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism. FASEB J. 27:3 (2013), 1095–1106.
31. [31] Izzo, R., Cipolletta, E., Ciccarelli, M., Campanile, A., Santulli, G., Palumbo, G., Vasta, A., Formisano, S., Trimarco, B., Iaccarino, G., Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin. Transl. Sci. 1:3 (2008), 215–220.
32. [32] Gros, R., Chorazyczewski, J., Meek, M.D., Benovic, J.L., Ferguson, S.S., Feldman, R.D., G-Protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 35:1 Pt 1 (2000), 38–42.
33. [33] De Boer, M.P., Meijer, R.I., Wijnstok, N.J., Jonk, A.M., Houben, A.J., Stehouwer, C.D., Smulders, Y.M., Eringa, E.C., Serne, E.H., Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 19:1 (2012), 5–18.
34. [34] Santulli, G., The adrenergic system in cardiovascular metabolism and aging. Lymperopoulos, A., (eds.) The Cardiovascular Adrenergic System, 2015, Springer, 97–116.
35. [35] White, M., Roden, R., Minobe, W., Khan, M.F., Larrabee, P., Wollmering, M., Port, J.D., Anderson, F., Campbell, D., Feldman, A.M., et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90:3 (1994), 1225–1238.
36. [36] Nakou, E.S., Parthenakis, F.I., Kallergis, E.M., Marketou, M.E., Nakos, K.S., Vardas, P.E., Healthy aging and myocardium: a complicated process with various effects in cardiac structure and physiology. Int. J. Cardiol. 209 (2016), 167–175.
37. [37] Xie, W., Santulli, G., Guo, X., Gao, M., Chen, B.X., Marks, A.R., Imaging atrial arrhythmic intracellular calcium in intact heart. J. Mol. Cell. Cardiol. 64 (2013), 120–123.
38. [38] Umanskaya, A., Santulli, G., Xie, W., Andersson, D.C., Reiken, S.R., Marks, A.R., Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging. Proc. Natl. Acad. Sci. U.S.A. 111:42 (2014), 15250–15255.
39. [39] Santulli, G., Xie, W., Reiken, S.R., Marks, A.R., Mitochondrial calcium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci. U.S.A., 112(36), 2015, 11389.
40. [40] Kirk, J.A., Holewinski, R.J., Kooij, V., Agnetti, G., Tunin, R.S., Witayavanitkul, N., de Tombe, P.P., Gao, W.D., Van Eyk, J., Kass, D.A., Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3beta. J. Clin. Invest. 124:1 (2014), 129–138.
41. [41] Wright, P.T., Nikolaev, V.O., O'Hara, T., Diakonov, I., Bhargava, A., Tokar, S., Schobesberger, S., Shevchuk, A.I., Sikkel, M.B., Wilkinson, R., Trayanova, N.A., Lyon, A.R., Harding, S.E., Gorelik, J., Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling. J. Mol. Cell. Cardiol. 67 (2014), 38–48.
42. [42] Santulli, G., Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon. Hypertension 63:2 (2014), 215–216.
43. [43] Santulli, G., Basilicata, M.F., De Simone, M., Del Giudice, C., Anastasio, A., Sorriento, D., Saviano, M., Del Gatto, A., Trimarco, B., Pedone, C., Zaccaro, L., Iaccarino, G., Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit. J. Transl. Med., 9, 2011, 7.
44. [44] Santulli, G., Wronska, A., Kunihiro, U., Diacovo, T., Gao, M., Marx, S., Kitajewski, J., Chilton, J., Kemal, M., Tuschl, T., Marks, A.R., Totary Jain, H., A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J. Clin. Invest. 124 (2014), 4102–4114.
45. [45] Santulli, G., microRNAs distinctively regulate vascular smooth muscle and endothelial cells: functional implications in angiogenesis, atherosclerosis, and in-stent restenosis. Adv. Exp. Med. Biol. 887 (2015), 53–77.
46. [46] Sorriento, D., Santulli, G., Del Giudice, C., Anastasio, A., Trimarco, B., Iaccarino, G., Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension 60:1 (2012), 129–136.
47. [47] Iaccarino, G., Ciccarelli, M., Sorriento, D., Galasso, G., Campanile, A., Santulli, G., Cipolletta, E., Cerullo, V., Cimini, V., Altobelli, G.G., Piscione, F., Priante, O., Pastore, L., Chiariello, M., Salvatore, F., Koch, W.J., Trimarco, B., Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ. Res. 97:11 (2005), 1182–1189.
48. [48] Santulli, G., microRNAs and endothelial (Dys) function. J. Cell. Physiol., 2015 in press.
49. [49] Santulli, G., Cipolletta, E., Sorriento, D., Del Giudice, C., Anastasio, A., Monaco, S., Maione, A.S., Condorelli, G., Puca, A., Trimarco, B., Illario, M., Iaccarino, G., CaMK4 gene deletion induces hypertension. J. Am. Heart Assoc., 1(4), 2012, e001081.
50. [50] Santulli, G., Coronary heart disease risk factors and mortality. JAMA, 307(11), 2012, 1137.
51. [51] Vu, T.H., Stamler, J., Liu, K., McDermott, M.M., Lloyd-Jones, D.M., Pirzada, A., Garside, D.B., Daviglus, M.L., Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up-the chicago healthy aging study. J. Am. Heart Assoc., 1(6), 2012, e001545.
52. [52] Sardu, C., Marfella, R., Santulli, G., Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J. Cardiovasc. Trans. Res. 7:3 (2014), 362–368.
53. [53] Ciccarelli, M., Finelli, R., Rivera, N., Santulli, G., Izzo, R., De Luca, N., Rozza, F., Ceccarelli, M., Pagnotta, S., Uliano, F., Tremigliozzi, R., Condorelli, G., Trimarco, V., Iaccarino, G., The possible role of chromosome X variability in hypertensive familiarity. J. Hum. Hypertens., 2016 in press.
54. [54] Begum, N., Shen, W., Manganiello, V., Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility. Curr. Opin. Pharmacol. 11:6 (2011), 725–729.
55. [55] Lavi, S., Nevo, O., Thaler, I., Rosenfeld, R., Dayan, L., Hirshoren, N., Gepstein, L., Jacob, G., Effect of aging on the cardiovascular regulatory systems in healthy women. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292:2 (2007), R788–R793.
56. [56] Menotti, A., Lanti, M., Mancini, M., Zanchetti, A., Laurenzi, M., Terradura Vagnarelli, O., Puddu, P., Moderate leisure time physical activity and occurrence of cardiovascular events: a 10-year follow-up in the gubbio population study. J. Cardiovasc. Dis. 2:5 (2014), 218–224.
57. [57] Ross, A.J., Gao, Z., Pollock, J.P., Leuenberger, U.A., Sinoway, L.I., Muller, M.D., Beta-adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men. Am. J. Physiol. Heart Circ. Physiol. 307:10 (2014), H1497–H1503.
58. [58] Huang, C.J., Slusher, A.L., Whitehurst, M., Wells, M., Mock, J.T., Maharaj, A., Shibata, Y., Acute aerobic exercise mediates G protein-coupled receptor kinase 2 expression in human PBMCs. Life Sci. 135 (2015), 87–91.
59. [59] Maffei, A., Vecchione, C., Aretini, A., Poulet, R., Bettarini, U., Gentile, M.T., Cifelli, G., Lembo, G., Characterization of nitric oxide release by nebivolol and its metabolites. Am. J. Hypertens. 19:6 (2006), 579–586.
60. [60] Maffei, A., Lembo, G., Nitric oxide mechanisms of nebivolol. Ther. Adv. Cardiovasc. Dis. 3:4 (2009), 317–327.
61. [61] De Rosa, R., Galasso, G., Piscione, F., Santulli, G., Pierri, A., Sorriento, D., Iaccarino, G., Trimarco, B., Chiariello, M., Beta2-adrenergic receptor improves the endothelial progenitor cells angiogenic function. Eur. Heart J., 30(S1), 2013, 353.
62. [62] Ciccarelli, M., Sorriento, D., Cipolletta, E., Santulli, G., Fusco, A., Zhou, R.H., Eckhart, A.D., Peppel, K., Koch, W.J., Trimarco, B., Iaccarino, G., Impaired neoangiogenesis in beta(2)-adrenoceptor gene-deficient mice: restoration by intravascular human beta(2)-adrenoceptor gene transfer and role of NFkappaB and CREB transcription factors. Br. J. Pharmacol. 162:3 (2011), 712–721.
63. [63] Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B., Iaccarino, G., Adrenergic receptors and metabolism: role in development of cardiovascular disease. Front. Physiol., 4, 2013, 265.
64. [64] Santulli, G., Ciccarelli, M., Trimarco, B., Iaccarino, G., Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the beta adrenergic system. Front. Physiol., 4, 2013, 209.
65. [65] Sorriento, D., Santulli, G., Franco, A., Cipolletta, E., Napolitano, L., Gambardella, J., Gomez-Monterrey, I., Campiglia, P., Trimarco, B., Iaccarino, G., Ciccarelli, M., Integrating GRK2 and NFkappaB in the pathophysiology of cardiac hypertrophy. J. Cardiovasc. Trans. Res. 8:8 (2015), 493–502.
66. [66] Czuriga, D., Paulus, W.J., Czuriga, I., Edes, I., Papp, Z., Borbely, A., Cellular mechanisms for diastolic dysfunction in the human heart. Curr. Pharm. Biotechnol. 13:13 (2012), 2532–2538.
67. [67] Xie, W., Santulli, G., Reiken, S.R., Yuan, Q., Osborne, B.W., Chen, B.X., Marks, A.R., Mitochondrial oxidative stress promotes atrial fibrillation. Sci. Rep., 5, 2015, 11427.
68. [68] Santulli, G., Iaccarino, G., De Luca, N., Trimarco, B., Condorelli, G., Atrial fibrillation and microRNAs. Front. Physiol., 5, 2014, 15.
69. [69] D'Ascia, S.L., D'Ascia, C., Marino, V., Lombardi, A., Santulli, R., Chiariello, M., Santulli, G., Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int. J. Clin. Pract. 65:11 (2011), 1149–1155.
70. [70] Santulli, G., D'Ascia, S.L., D'Ascia, C., Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling. Can. J. Cardiol., 28(2), 2012 245 e17.
71. [71] Lanni, F., Santulli, G., Izzo, R., Rubattu, S., Zanda, B., Volpe, M., Iaccarino, G., Trimarco, B., The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J. Hypertens. 25:3 (2007), 551–556.
72. [72] Sorriento, D., Santulli, G., Fusco, A., Anastasio, A., Trimarco, B., Iaccarino, G., Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension 56:4 (2010), 696–704.
73. [73] Hees, P.S., Fleg, J.L., Lakatta, E.G., Shapiro, E.P., Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am. J. Cardiol. 90:11 (2002), 1231–1236.
74. [74] Cantini, C., Kieffer, P., Corman, B., Liminana, P., Atkinson, J., Lartaud-Idjouadiene, I., Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension 38:4 (2001), 943–948.
75. [75] Iaccarino, G., Ciccarelli, M., Sorriento, D., Cipolletta, E., Cerullo, V., Iovino, G.L., Paudice, A., Elia, A., Santulli, G., Campanile, A., Arcucci, O., Pastore, L., Salvatore, F., Condorelli, G., Trimarco, B., AKT participates in endothelial dysfunction in hypertension. Circulation 109:21 (2004), 2587–2593.
76. [76] Santulli, G., Pagano, G., Sardu, C., Xie, W., Reiken, S., D'Ascia, S.L., Cannone, M., Marziliano, N., Trimarco, B., Guise, T.A., Lacampagne, A., Marks, A.R., Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J. Clin. Invest. 125:5 (2015), 1968–1978.
77. [77] Heinonen, I., Wendelin-Saarenhovi, M., Kaskinoro, K., Knuuti, J., Scheinin, M., Kalliokoski, K.K., Inhibition of alpha-adrenergic tone disturbs the distribution of blood flow in the exercising human limb. Am. J. Physiol. Heart Circ. Physiol. 305:2 (2013), H163–H172.
78. [78] Perino, A., Ghigo, A., Ferrero, E., Morello, F., Santulli, G., Baillie, G.S., Damilano, F., Dunlop, A.J., Pawson, C., Walser, R., Levi, R., Altruda, F., Silengo, L., Langeberg, L.K., Neubauer, G., Heymans, S., Lembo, G., Wymann, M.P., Wetzker, R., Houslay, M.D., Iaccarino, G., Scott, J.D., Hirsch, E., Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol. Cell 42:1 (2011), 84–95.
79. [79] Wu, L., Liu, L., Systematic review and meta-analysis evaluating the impact of vitamin D on the risk of heart failure: new evidence from population-based studies. J. Cardiovasc. Dis. 2:3 (2014), 159–173.
80. [80] Al Maluli, H., DeStephan, C., Hemodynamic monitoring in the intensive care unit. J. Cardiovasc. Dis. 2:2 (2014), 101–115.
81. [81] Sardu, C., Marfella, R., Santulli, G., Paolisso, G., Functional role of miRNA in cardiac resynchronization therapy. Pharmacogenomics 15:8 (2014), 1159–1168.
82. [82] Nguyen, M.N., Kiriazis, H., Ruggiero, D., Gao, X.M., Su, Y., Jian, A., Han, L.P., McMullen, J.R., Du, X.J., Spontaneous ventricular tachyarrhythmias in beta2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis. Am. J. Physiol. Heart Circ. Physiol. 309:5 (2015), H946–H947.
83. [83] Ritchie, R.H., Leo, C.H., Qin, C., Stephenson, E.J., Bowden, M.A., Buxton, K.D., Lessard, S.J., Rivas, D.A., Koch, L.G., Britton, S.L., Hawley, J.A., Woodman, O.L., Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function. Am. J. Physiol. Heart Circ. Physiol. 304:5 (2013), H729–H739.
84. [84] Ho, D., Yan, L., Iwatsubo, K., Vatner, D.E., Vatner, S.F., Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. Heart Fail. Rev. 15:5 (2010), 495–512.
85. [85] Dorn 2nd, G.W., Tepe, N.M., Lorenz, J.N., Koch, W.J., Liggett, S.B., Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc. Natl. Acad. Sci. U.S.A. 96:11 (1999), 6400–6405.
86. [86] Tevaearai, H.T., Eckhart, A.D., Walton, G.B., Keys, J.R., Wilson, K., Koch, W.J., Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 106:1 (2002), 124–129.
87. [87] Engelhardt, S., Hein, L., Wiesmann, F., Lohse, M.J., Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 96:12 (1999), 7059–7064.
88. [88] Du, X.J., Gao, X.M., Wang, B., Jennings, G.L., Woodcock, E.A., Dart, A.M., Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart. Cardiovasc. Res. 48:3 (2000), 448–454.
89. [89] Lymperopoulos, A., Chowdhary, S., Sankar, K., Simon, I., Regulation of catecholamine production from the adrenal medulla. Santulli, G., (eds.) Adrenal Glands: From Pathophysiology to Clinical Evidence, 2015, Nova Science Publisher, New York, NY.
90. [90] Thireau, J., Karam, S., Roberge, S., Roussel, J., Aimond, F., Cassan, C., Gac, A., Babuty, D., Le Guennec, J.Y., Lacampagne, A., Fauconnier, J., Richard, S., Beta-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?. Heart 100:11 (2014), 833–841.
91. [91] Shiny, K.S., Kumar, S.H., Farvin, K.H., Anandan, R., Devadasan, K., Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. J. Pharm. Pharmacol. 57:10 (2005), 1313–1317.
92. [92] Huang, C.J., Webb, H.E., Zourdos, M.C., Acevedo, E.O., Cardiovascular reactivity, stress, and physical activity. Front. Physiol., 4, 2013, 314.
93. [93] Weng, T.P., Fu, T.C., Wang, C.H., Hsu, C.C., Wang, J.S., Activation of lymphocyte autophagy/apoptosis reflects haemodynamic inefficiency and functional aerobic impairment in patients with heart failure. Clin. Sci. 127:10 (2014), 589–602.
94. [94] Berezin, A., Kremzer, A., Samura, T., Martovitskaya, Y., Apoptotic microparticles to progenitor mononuclear cells ratio in heart failure: relevance of clinical status and outcomes. J. Cardiovasc. Dis. 2:2 (2014), 50–57.
95. [95] Ciccarelli, M., Santulli, G., Campanile, A., Galasso, G., Cervero, P., Altobelli, G.G., Cimini, V., Pastore, L., Piscione, F., Trimarco, B., Iaccarino, G., Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br. J. Pharmacol. 153:5 (2008), 936–946.
96. [96] Buroker, N., ADRBK1 (GRK2) rSNPs transcriptional factor binding sites and cardiovascular disease in the black population. J. Cardiovasc. Dis. 2:2 (2014), 62–67.
97. [97] Santulli, G., Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. J. Cardiovasc. Dis. 1:1 (2013), 1–2.
98. [98] Philipson, L.H., Beta-agonists and metabolism. J. Allergy Clin. Immunol. 110:6 Suppl (2002), S313–7.
99. [99] Ngala, R.A., O'Dowd, J., Wang, S.J., Agarwal, A., Stocker, C., Cawthorne, M.A., Arch, J.R., Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms. Br. J. Pharmacol. 155:3 (2008), 395–406.
100. [100] Sakamoto, K., Holman, G.D., Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. 295:1 (2008), E29–E37.
101. [101] Maarbjerg, S.J., Sylow, L., Richter, E.A., Current understanding of increased insulin sensitivity after exercise—emerging candidates. Acta Physiol. (Oxford England) 202:3 (2011), 323–335.
102. [102] Perez-Schindler, J., Philp, A., Baar, K., Hernandez-Cascales, J., Regulation of contractility and metabolic signaling by the beta2-adrenergic receptor in rat ventricular muscle. Life Sci. 88:19–20 (2011), 892–897.
103. [103] Bruzzone, A., Sauliere, A., Finana, F., Senard, J.M., Luthy, I., Gales, C., Dosage-dependent regulation of cell proliferation and adhesion through dual beta2-adrenergic receptor/cAMP signals. FASEB J. 28:3 (2014), 1342–1354.
104. [104] Hardie, D.G., Ross, F.A., Hawley, S.A., AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. 13:4 (2012), 251–262.
105. [105] Nikolaidis, L.A., Poornima, I., Parikh, P., Magovern, M., Shen, Y.T., Shannon, R.P., The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. J. Am. Coll. Cardiol. 47:9 (2006), 1871–1881.
106. [106] Shahid, G., Hussain, T., GRK2 negatively regulates glycogen synthesis in mouse liver FL83B cells. J. Biol. Chem. 282:28 (2007), 20612–20620.
107. [107] Lupien, J.R., Hirshman, M.F., Horton, E.S., Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness. Am. J. Physiol. 259:2 Pt 1 (1990), E210–E215.
108. [108] Straznicky, N.E., Grima, M.T., Sari, C.I., Eikelis, N., Lambert, E.A., Nestel, P.J., Esler, M.D., Dixon, J.B., Chopra, R., Tilbrook, A.J., Schlaich, M.P., Lambert, G.W., Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 61:10 (2012), 2506–2516.
109. [109] on behalf of the Toronto Consensus Panel on Diabetic, Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop-Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., Low, P., Valensi, P., Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab. Res. Rev., 2011.
110. [110] Quinones, M.J., Nicholas, S.B., Lyon, C.J., Insulin resistance and the endothelium. Curr. Diab. Rep. 5:4 (2005), 246–253.
111. [111] Straznicky, N.E., Lambert, E.A., Nestel, P.J., McGrane, M.T., Dawood, T., Schlaich, M.P., Masuo, K., Eikelis, N., de Courten, B., Mariani, J.A., Esler, M.D., Socratous, F., Chopra, R., Sari, C.I., Paul, E., Lambert, G.W., Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 59:1 (2010), 71–79.
112. [112] Oriente, F., Iovino, S., Cassese, A., Romano, C., Miele, C., Troncone, G., Balletta, M., Perfetti, A., Santulli, G., Iaccarino, G., Valentino, R., Beguinot, F., Formisano, P., Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. Diabetologia 52:12 (2009), 2642–2652.
113. [113] Schernthaner, G., Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors. Int. J. Clin. Pract. 63:6 (2009), 912–929.
114. [114] Fu, Q., Xu, B., Liu, Y., Parikh, D., Li, J., Li, Y., Zhang, Y., Riehle, C., Zhu, Y., Rawlings, T., Shi, Q., Clark, R.B., Chen, X., Abel, E.D., Xiang, Y.K., Insulin inhibits cardiac contractility by inducing a Gi-biased beta2 adrenergic signaling in hearts. Diabetes, 2014.
115. [115] Wright, J.J., Kim, J., Buchanan, J., Boudina, S., Sena, S., Bakirtzi, K., Ilkun, O., Theobald, H.A., Cooksey, R.C., Kandror, K.V., Abel, E.D., Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc. Res. 82:2 (2009), 351–360.
116. [116] Azevedo, P.S., Minicucci, M.F., Santos, P.P., Paiva, S.A., Zornoff, L.A., Energy metabolism in cardiac remodeling and heart failure. Cardiol. Rev. 21:3 (2013), 135–140.
117. [117] Glatz, J.F., Luiken, J.J., Bonen, A., Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 90:1 (2010), 367–417.
118. [118] Shimizu, I., Minamino, T., Toko, H., Okada, S., Ikeda, H., Yasuda, N., Tateno, K., Moriya, J., Yokoyama, M., Nojima, A., Koh, G.Y., Akazawa, H., Shiojima, I., Kahn, C.R., Abel, E.D., Komuro, I., Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Invest. 120:5 (2010), 1506–1514.
119. [119] Avendano, M.S., Lucas, E., Jurado-Pueyo, M., Martinez-Revelles, S., Vila-Bedmar, R., Mayor, F., Salaices, M. Jr., Briones, A.M., Murga, C., Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension. Hypertension 63:2 (2014), 369–375.
120. [120] Cipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B., Iaccarino, G., The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cardiovasc. Res. 84:3 (2009), 407–415.
121. [121] Watari, K., Nakaya, M., Kurose, H., Multiple functions of G protein-coupled receptor kinases. J. Mol. Signal., 9(1), 2014, 1.
122. [122] Fusco, A., Santulli, G., Sorriento, D., Cipolletta, E., Garbi, C., Dorn2nd, G.W., Trimarco, B., Feliciello, A., Iaccarino, G., Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell. Signal. 24:2 (2012), 468–475.
123. [123] Chen, M., Sato, P.Y., Chuprun, J.K., Peroutka, R.J., Otis, N.J., Ibetti, J., Pan, S., Sheu, S.S., Gao, E., Koch, W.J., Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting. Circ. Res. 112:8 (2013), 1121–1134.
124. [124] Sorriento, D., Ciccarelli, M., Santulli, G., Illario, M., Trimarco, B., Iaccarino, G., Trafficking GRK2: cellular and metabolic consequences of GRK2 subcellular localization. Transl. Med. UniSa 10 (2014), 3–7.
125. [125] Lin, L.Y., Wu, C.K., Juang, J.M., Wang, Y.C., Su, M.Y., Lai, L.P., Hwang, J.J., Chiang, F.T., Tseng, W.Y., Lin, J.L., Myocardial regional interstitial fibrosis is associated with left intra-Ventricular dyssynchrony in patients with heart failure: a cardiovascular magnetic resonance study. Sci. Rep., 6, 2016, 20711.
126. [126] Trial, J., Entman, M.L., Cieslik, K.A., Mesenchymal stem cell-derived inflammatory fibroblasts mediate interstitial fibrosis in the aging heart. J. Mol. Cell. Cardiol. 91 (2016), 28–34.
127. [127] Schelbert, E.B., Piehler, K.M., Zareba, K.M., Moon, J.C., Ugander, M., Messroghli, D.R., Valeti, U.S., Chang, C.C., Shroff, S.G., Diez, J., Miller, C.A., Schmitt, M., Kellman, P., Butler, J., Gheorghiade, M., Wong, T.C., Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J. Am. Heart Assoc., 4(12), 2015.
128. [128] Dai, D.F., Rabinovitch, P.S., Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc. Med. 19:7 (2009), 213–220.
129. [129] Horn, M.A., Trafford, A.W., Aging and the cardiac collagen matrix: novel mediators of fibrotic remodelling. J. Mol. Cell. Cardiol., 2015 in press.
130. [130] Iwanaga, Y., Aoyama, T., Kihara, Y., Onozawa, Y., Yoneda, T., Sasayama, S., Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J. Am. Coll. Cardiol. 39:8 (2002), 1384–1391.
131. [131] Seeland, U., Selejan, S., Engelhardt, S., Muller, P., Lohse, M.J., Bohm, M., Interstitial remodeling in beta1-adrenergic receptor transgenic mice. Basic Res. Cardiol. 102:2 (2007), 183–193.
132. [132] Kato, S., Spinale, F.G., Tanaka, R., Johnson, W., Cooper, G.t., Zile, M.R., Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am. J. Physiol. 269:3 Pt 2 (1995), H863–H868.
133. [133] Communal, C., Singh, M., Menon, B., Xie, Z., Colucci, W.S., Singh, K., beta1 integrins expression in adult rat ventricular myocytes and its role in the regulation of beta-adrenergic receptor-stimulated apoptosis. J. Cell. Biochem. 89:2 (2003), 381–388.
134. [134] Banfi, C., Cavalca, V., Veglia, F., Brioschi, M., Barcella, S., Mussoni, L., Boccotti, L., Tremoli, E., Biglioli, P., Agostoni, P., Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure. Eur. Heart J. 26:5 (2005), 481–488.